Aldeyra Therapeutics
ALDX
$4.03
Share price
2.54%
Change (1 day)
-57.71%
Change (1 year)
Categories
Earnings for Aldeyra Therapeutics (ALDX)
Earnings in 2023 (TTM): -$35.48 M
According to Aldeyra Therapeutics 's latest financial reports the company's current earnings (TTM) are -$35.48 M. In 2022 the company made an earning of -$60.34 M a decrease over its 2021 earnings that were of -$56.04 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Aldeyra Therapeutics from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$35.48 M | -41.21% |
| 2022 | -$60.34 M | 7.67% |
| 2021 | -$56.04 M | 55.1% |
| 2020 | -$36.13 M | -41.29% |
| 2019 | -$61.54 M | 58.81% |
| 2018 | -$38.75 M | 74.32% |
| 2017 | -$22.23 M | 19.56% |
| 2016 | -$18.6 M | 55.21% |
| 2015 | -$11.98 M | 142.32% |
| 2014 | -$4.95 M | -137.39% |
| 2013 | $13.21 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | $4.19 B | -11,938.65% | 🇺🇸 USA |